NCT00470821View on ClinicalTrials.gov

Oral Melatonin in Critically Ill High-risk Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
Critically Ill PatientsMechanically Ventilated Patients
Interventions
DRUG

Oral melatonin 3mg BID

Identical tablets containing melatonin 3 mg. Nurses are requested to give two tablets daily, at 8 PM and 12 PM

DRUG

Placebo

Identical tablets without the active principles. Each evening nurses are requested to give 2 tablets at 8 PM and 12 PM

Trial Locations (1)

20142

Azienda Ospedaliera San Paolo - Polo Universitario, Milan

All Listed Sponsors
lead

University of Milan

OTHER

NCT00470821 - Oral Melatonin in Critically Ill High-risk Patients | Biotech Hunter | Biotech Hunter